Showing results (931-940 of 3,886) with videos related to

Sort By:
Pageof 389
Cancer Biology & Therapy|August 6, 2005
Radiolabeling and biological evaluation of DOTA-Ph-Al derivative conjugated to anti-EGFR antibody ior egf/r3 for targeted tumor imaging and therapyPuja Pnwar, Normando Iznaga-Escobar, Pushpa Mishra, et al.
Cancer Biology & Therapy|June 22, 2026
KIF18A inhibitor prevents chromosomally unstable osteosarcoma growth by activating spindle assembly checkpointQiang Yan, Yan Zhang, Pengfei Wang, et al.
Cancer Biology & Therapy|July 2, 2026
Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptidesBernardo Chavez, Vitali Sikirzhytski, Chang-Uk Lim, et al.
Cancer Biology & Therapy|June 19, 2026
Opsonization and timing as key determinants of MBTA immunotherapy efficacy in pancreatic adenocarcinoma and recurrence treatmentAndrea Frejlachova, Radka Lencova, Ondrej Uher, et al.
Cancer Biology & Therapy|June 23, 2026
Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude versus low-altitude regions: a multi-center retrospective studyYujing Tan, Yinyin Ye, Weihong Zhao, et al.
Cancer Biology & Therapy|June 26, 2026
ABHD17C regulates the efficacy of lenvatinib in suppressing hepatocellular carcinomaLinpei Wang, Jiawei Wang, Xiaoqiu Ma, et al.
Cancer Biology & Therapy|June 4, 2026
Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biologyXing Liu, Hejin Zhang, Renchun Du, et al.
Cancer Biology & Therapy|April 22, 2026
Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study with external historical controlLi-Wei Lyu, Na Yao, Zi-Xian Liu, et al.
Cancer Biology & Therapy|May 26, 2026
Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosisChenguang Liu, Shiyang Liu, Zonghong Lu, et al.
Cancer Biology & Therapy|July 20, 2026
Bis-(di-4-phenyl-benzylaminethiocarbonyl)disulfide sensitizes ABCC2/ALDH3A1 overexpressing NSCLC cells to cisplatinJolanta Kryczka, Jakub Mateusz Kryczka, Łukasz Janczewski, et al.
Pageof 389